These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35398308)

  • 1. Downregulation of SHMT2 promotes the prostate cancer proliferation and metastasis by inducing epithelial-mesenchymal transition.
    Chen L; Liu H; Ji Y; Ma Z; Shen K; Shangguan X; Qian H; Zhao Y; Pan CW; Xue W
    Exp Cell Res; 2022 Jun; 415(2):113138. PubMed ID: 35398308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells.
    Ji L; Tang Y; Pang X; Zhang Y
    Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma.
    Woo CC; Chen WC; Teo XQ; Radda GK; Lee PT
    Oncotarget; 2016 Aug; 7(33):53005-53017. PubMed ID: 27391339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shmt2: A Stat3 Signaling New Player in Prostate Cancer Energy Metabolism.
    Marrocco I; Altieri F; Rubini E; Paglia G; Chichiarelli S; Giamogante F; Macone A; Perugia G; Magliocca FM; Gurtner A; Maras B; Ragno R; Patsilinakos A; Manganaro R; Eufemi M
    Cells; 2019 Sep; 8(9):. PubMed ID: 31500219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation.
    Liu C; Wang L; Liu X; Tan Y; Tao L; Xiao Y; Deng P; Wang H; Deng Q; Lin Y; Jie H; Zhang H; Zhang J; Peng Y; Zhang H; Zhou Z; Sun Q; Cen X; Zhao Y
    Theranostics; 2021; 11(6):2966-2986. PubMed ID: 33456583
    [No Abstract]   [Full Text] [Related]  

  • 6. Serine hydroxymethyltransferase 2 (SHMT2) potentiates the aggressive process of oral squamous cell carcinoma by binding to interleukin enhancer-binding factor 2 (ILF2).
    Zhang H; Che Y; Xuan B; Wu X; Li H
    Bioengineered; 2022 Apr; 13(4):8785-8797. PubMed ID: 35333683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT.
    Huo FC; Xie M; Zhu ZM; Zheng JN; Pei DS
    Genomics; 2022 Jul; 114(4):110424. PubMed ID: 35798250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression.
    Cui X; Cui Y; Du T; Jiang X; Song C; Zhang S; Ma C; Liu Y; Ni Q; Gao Y; Wang G
    Can J Gastroenterol Hepatol; 2022; 2022():3758697. PubMed ID: 35211429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma.
    Clark RA; Qiao J; Jacobson JC; Chung DH
    Oncotarget; 2022; 13():32-45. PubMed ID: 35018218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma.
    Wu X; Deng L; Tang D; Ying G; Yao X; Liu F; Liang G
    Tumour Biol; 2016 May; 37(5):6813-21. PubMed ID: 26662310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling.
    Wang W; Wang M; Du T; Hou Z; You S; Zhang S; Ji M; Xue N; Chen X
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer proteome and metabolite changes linked to SHMT2.
    Tong J; Krieger JR; Taylor P; Bagshaw R; Kang J; Jeedigunta S; Wybenga-Groot LE; Zhang W; Badr H; Mirhadi S; Pham NA; Coyaud É; Yu M; Li M; Cabanero M; Raught B; Maynes JT; Hawkins C; Tsao MS; Moran MF
    PLoS One; 2020; 15(9):e0237981. PubMed ID: 32903271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine hydroxymethyltransferase 2: a novel target for human cancer therapy.
    Xie M; Pei DS
    Invest New Drugs; 2021 Dec; 39(6):1671-1681. PubMed ID: 34215932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing.
    Parsa S; Ortega-Molina A; Ying HY; Jiang M; Teater M; Wang J; Zhao C; Reznik E; Pasion JP; Kuo D; Mohan P; Wang S; Camarillo JM; Thomas PM; Jain N; Garcia-Bermudez J; Cho BK; Tam W; Kelleher NL; Socci N; Dogan A; De Stanchina E; Ciriello G; Green MR; Li S; Birsoy K; Melnick AM; Wendel HG
    Nat Cancer; 2020; 1():653-664. PubMed ID: 33569544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Notch pathway is linked with epithelial-mesenchymal transition in prostate cancer cells.
    Zhang L; Sha J; Yang G; Huang X; Bo J; Huang Y
    Cell Cycle; 2017 May; 16(10):999-1007. PubMed ID: 28388267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation.
    Yang X; Wang Z; Li X; Liu B; Liu M; Liu L; Chen S; Ren M; Wang Y; Yu M; Wang B; Zou J; Zhu WG; Yin Y; Gu W; Luo J
    Cancer Res; 2018 Jan; 78(2):372-386. PubMed ID: 29180469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis.
    Wei Z; Song J; Wang G; Cui X; Zheng J; Tang Y; Chen X; Li J; Cui L; Liu CY; Yu W
    Nat Commun; 2018 Oct; 9(1):4468. PubMed ID: 30367038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
    Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
    J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine hydroxymethyltransferase 2 knockdown induces apoptosis in ccRCC by causing lysosomal membrane permeabilization via metabolic reprogramming.
    Liu Z; Fan M; Hou J; Pan S; Xu Y; Zhang H; Liu C; Hao X; Li X; Wang H
    Cell Death Dis; 2023 Feb; 14(2):144. PubMed ID: 36806313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
    Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
    Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.